Cart
0

U.S. IVD Market by Product Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and by End Users (Standalone Laboratory, Hospitals, Academic and Medical Schools, Point of Care Testing, and Others) - Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_173817
Pages: 140
Sep 2017 | 1696 Views
 
Author's : Abha Thakur
Tables: 39
Charts: 54
 

U.S. IVD Market Overview:

U.S. IVD Market accounted for $15,746 million in 2016, and is estimated to reach at $20,707 million by 2023, growing at a CAGR of 3.9% from 2017 to 2023. In vitro diagnostics (IVD) are intended for in vitro analysis of samples derived from the human body, to provide information for diagnostic, monitoring, and treatment purposes. They are used for diagnosis of various diseases such as infectious, cardiovascular, cancer, and others.

Increase in prevalence of chronic and infectious diseases such as tuberculosis, diabetes, and lifestyle diseases and increase in geriatric population in the U.S. primarily drives the market. In addition, implementation of the Affordable Care Act (ACA) and increase in adoption of automated instruments in laboratories that enable accurate and fast test results have increased the IVD market growth. Furthermore, advert of point of care diagnosis and personalized medicine is anticipated to boost the market growth. However, lack of favorable reimbursement policies and stringent government regulations associated to the product approval, manufacturing, and sale of IVD are expected to hamper the market growth. Ongoing R&D activities related to IVD are anticipated to present new opportunities for the market.

U.S. IVD Market Segmentation

U.S. IVD Market Segmentation

Get more information on this report : Request Sample Pages

 Segment review

Based on product type, the market is categorized into reagents, instruments, and software & services. The reagent segment accounted for the highest market share in 2016, and the software and services is expected to grow at the highest growth rate during the forecast period. The growth of the reagent market is attributed to the wide availability of effective and cost-efficient reagents. On the basis of techniques, the immunodiagnostics accounted for the highest market share in 2016, owing to the increase in demand for personalized medicines for genetic diseases and cancer screening. On the basis of application, the infectious disease segment captured the highest market share in 2016, owing to the increase in prevalence of lifestyle diseases and infectious diseases among the population. Based on end users, the standalone laboratory segment captured the highest market share in 2016, primarily due to increase in outsourcing of test to the laboratories as they provide accurate and fast test results.

Top Investment Pocket

U.S. IVD Market Top Investment Pocket

Get more information on this report : Request Sample Pages

 Increase in prevalence of chronic and infectious diseases

In past few decades, cases of increase in prevalence of chronic and infectious diseases have reached an alarming proportion due to an increasingly morbid lifestyle such as high body mass index, low fruit and vegetable intake, lack of physical activity, and high tobacco and alcohol use. According to the American Cancer Society estimates, in 2017 the cancer deaths accounted for approximately 600,920 and new cancer diagnosed cases accounted for approximately 1,688,780 cases in the U.S. The increase in rate of diseases have increased the demand for IVD market.

Increase in geriatric population

Aging population is on an increase, which results in rise in number of people in need of medical assistance. Growth in average life expectancies along with more affluent population improve healthcare expenditure by using the advanced in vitro diagnostic technologies for monitoring their health. According to the U.S. Census Bureau report “’An Aging World: 2015”, 46 million of the U.S. population comprises of population aged 65 years and above. This number is predicted to increase to nearly 98 million 2050. This escalation in rate of the geriatric population is expected to raise the demand for diagnosis, thereby driving the IVD market.

Technological advancements in IVD

The healthcare industry is developing at a significant rate due to demand for better healthcare services, significant investments by governments to improve healthcare infrastructure, rise in focus on the improvement of effectiveness, and safety of the medical devices. Earlier, molecular testing was time consuming and costly, but these days with automated technology one can get accurate, cost effective and quick results. For instance, in August 2016, FDA approved Alere Inc. product of Alere i RSV test, the first rapid molecular test that can be used at the point-of-care to detect RSV infection in 13 minutes or less.

Major companies operating in this market adopt product launch as their key development strategy. Companies profiled in this market include, Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson among others.

Key Benefits

  • The study provides an in-depth analysis of the U.S. IVD market along with current trends and future estimations to elucidate the imminent investment pockets.
  • Quantitative analysis of the industry is provided for the period of 2016‐2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • Extensive analysis by technique and application helps understand various trends and prevailing opportunities in the market.
  • The key market players are profiled and their strategies are analyzed to predict the competitive outlook of the market.

U.S. IVD Market Key Segments:

By Product Type

  • Reagents
  • Instruments
  • Software and Services

By Techniques

  • Immunodiagnostics
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassays (CLIAS)
      • Fluorescence Immunoassays (FIAS)
      • Colorimetric Immunoassays (CIS)
    • Rapid Tests
    • Enzyme-Linked Immunospot Assays (ELISPOT)
    • Radioimmunoassay
    • Western Blot
  • Blood Testing
  • Molecular Diagnostics
    • Polymerase Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridization
    • DNA Diagnostics
    • Microarrays
    • Others
  • Tissue Diagnostics
  • Clinical Chemistry
    • Basic Metabolic Panel
    • Liver Panel
    • Lipid Profile
    • Thyroid Function Panel
    • Renal Profile
    • Electrolyte Panel
    • Specialty Chemicals
  • Other IVD Techniques

By Application

  • Infectious Diseases
  • Cancer
  • Cardiac Diseases
  • Immune System Disorders
  • Nephrological Diseases
  • Gastrointestinal Diseases
  • Other Indications

By End Users

  • Standalone Laboratory
  • Hospitals
  • Academic and Medical Schools
  • Point of Care Testing
  • Others
 

Chapter: 1 INTRODUCTION

1.1 REPORT DESCRIPTION
1.2 KEY BENEFITS
1.3 KEY MARKET SEGMENTS
1.4 RESEARCH METHODOLOGY

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1 MARKET DEFINITION AND SCOPE
3.2 KEY FINDINGS

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 PORTER’S FIVE FORCES ANALYSIS

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Threat of substitute
3.3.5 Competitive rivalry

3.4 MARKET SHARE ANALYSIS, 2016
3.5 MARKET DYNAMICS

3.5.1 Drivers

3.5.1.1 Increasing incidence of chronic and infectious diseases
3.5.1.2 Technological advancements in IVD
3.5.1.3 Emergence of minimal invasive technologies
3.5.1.4 Increasing government expenditures on healthcare
3.5.1.5 Increase in popularity of personalized medicine approach

3.5.2 Restraint

3.5.2.1 Unclear reimbursement policies
3.5.2.2 Stringent regulatory policies

3.5.3 Opportunity

3.5.3.1 Potential opportunities for outsourcing
3.5.3.2 Convergence of new technologies

Chapter: 4 IVD MARKET, BY PRODUCT TYPE

4.1 OVERVIEW

4.1.1 Market size and forecast

4.2 REAGENTS

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 INSTRUMENTS

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 SOFTWARE AND SERVICES

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

Chapter: 5 IVD MARKET, BY TECHNIQUE

5.1 OVERVIEW

5.1.1 Market size and forecast

5.2 IMMUNODIAGNOSTICS

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 Enzyme-linked immunosorbent assay (ELISA)

5.2.4.1 Market size and forecast
5.2.4.2 Chemiluminescence immunoassay (CLIA)

5.2.4.2.1 Market size and forecast

5.2.4.3 Fluorescence immunoassay (FIA)

5.2.4.3.1 Market size and forecast

5.2.4.4 Colorimetric immunoassay (CI)

5.2.4.4.1 Market size and forecast

5.2.5 Rapid tests

5.2.5.1 Market size and forecast

5.2.6 Enzyme-linked immunospot (ELISPOT)

5.2.6.1 Market size and forecast

5.2.7 Radioimmunoassay (RIA)

5.2.7.1 Market size and forecast

5.2.8 Western blot

5.2.8.1 Market size and forecast

5.3 BLOOD TESTING

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

5.4 MOLECULAR DIAGNOSTICS

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Polymerize chain reaction (PCR)

5.4.4.1 Market size and forecast

5.4.5 Isothermal nucleic acid technology (INAAT)

5.4.5.1 Market size and forecast

5.4.6 Hybridization

5.4.6.1 Market size and forecast

5.4.7 DNA diagnostics

5.4.7.1 Market size and forecast

5.4.8 Microarray

5.4.8.1 Market size and forecast

5.4.9 Others

5.4.9.1 Market size and forecast

5.5 TISSUE DIAGNOSTICS

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast

5.6 CLINICAL CHEMISTRY

5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
5.6.4 Basic metabolic panel

5.6.4.1 Market size and forecast

5.6.5 Liver panel

5.6.5.1 Market size and forecast

5.6.6 Renal profile

5.6.6.1 Market size and forecast

5.6.7 Lipid profile

5.6.7.1 Market size and forecast

5.6.8 Thyroid function panel

5.6.8.1 Market size and forecast

5.6.9 Electrolyte panel

5.6.9.1 Market size and forecast

5.6.10 Speciality chemicals

5.6.10.1 Market size and forecast

5.7 OTHER IVD TECHNIQUES

5.7.1 Key market trends
5.7.2 Key growth factors and opportunities
5.7.3 Market size and forecast

Chapter: 6 IVD MARKET, BY APPLICATION

6.1 INFECTIOUS DISEASES

6.1.1 Key market trends
6.1.2 Key growth factors and opportunities
6.1.3 Market size and forecast

6.2 CANCER

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.3 CARDIAC DISEASES

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.4 IMMUNE SYSTEM DISORDERS

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.5 NEPHROLOGICAL DISEASES

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

6.6 GASTROINTESTINAL DISEASES

6.6.1 Key market trends
6.6.2 Key growth factors and opportunities
6.6.3 Market size and forecast

6.7 OTHERS INDICATIONS

6.7.1 Key market trends
6.7.2 Key growth factors and opportunities
6.7.3 Market size and forecast

Chapter: 7 IVD MARKET BY END USERS

7.1 STANDALONE LABORATORIES

7.1.1 Market size and forecast

7.2 HOSPITALS

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast

7.3 ACADEMIC AND MEDICAL SCHOOLS

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast

7.4 POINT OF CARE TESTING

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast

7.5 OTHERS END-USER

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast

Chapter: 8 COMPANY PROFILES

8.1 THERMO FISHER SCIENTIFIC INC.

8.1.1 Company overview
8.1.2 Business performance
8.1.3 Key strategies and development

8.2 ALERE INC.

8.2.1 Company overview
8.2.2 Business performance
8.2.3 Key strategies and developments

8.3 BIOMERIEUX

8.3.1 Company overview
8.3.2 Business performance
8.3.3 Key strategies and developments

8.4 DANAHER CORPORATION

8.4.1 Company overview
8.4.2 Business performance
8.4.3 Key strategies and development

8.5 F. HOFFMANN-LA ROCHE AG

8.5.1 Company overview
8.5.2 Business performance
8.5.3 Key strategies and developments

8.6 BECTON DICKINSON AND COMPANY

8.6.1 Company overview
8.6.2 Business performance
8.6.3 Key strategies and development

8.7 BIO-RAD LABORATORIES

8.7.1 Company overview
8.7.2 Business performance
8.7.3 Key strategies and developments

8.8 BAYER AG

8.8.1 Company overview
8.8.2 Business performance
8.8.3 Key strategies and development

8.8 SYSMEX CORPORATION

8.8.1 Company overview
8.8.2 Business performance
8.8.3 Key strategies and developments

8.10 JOHNSON & JOHNSON

8.10.1 Company overview
8.10.2 Business performance
8.10.3 Key strategies and development

List of Figures

FIGURE 1 MARKET SEGMENTATION
FIGURE 2 TOP INVESTMENT POCKETS
FIGURE 3 TOP WINNING STRATEGIES, 2014-2016 (%)
FIGURE 4 TOP WINNING STRATEGIES: NATURE AND TYPE, 2014-2016
FIGURE 5 PORTER’S FIVE FORCES ANALYSIS
FIGURE 6 MARKET SHARE ANALYSIS: IVD MARKET, 2016
FIGURE 7 U.S. CHEMILUMINESCENCE IMMUNOASSAY (CLISA) MARKET, 2016-2023 ($MILLION)
FIGURE 8 U.S. FLUORESCENCE IMMUNOASSAY (FIA) MARKET, 2016-2023 ($MILLION)
FIGURE 9 U.S. COLORIMETRIC IMMUNOASSAY (CI) MARKET, 2016-2023 ($MILLION)
FIGURE 10 U.S. RAPID TESTS MARKET, 2016-2023 ($MILLION)
FIGURE 11 U.S. ENZYME-LINKED IMMUNOSPOT (ELISPOT) MARKET, 2016-2023 ($MILLION)
FIGURE 12 U.S. RADIOIMMUNOASSAY (RIA) MARKET, 2016-2023 ($MILLION)
FIGURE 13 U.S. WESTERN BLOT TECHNIQUE MARKET, 2016-2023 ($MILLION)
FIGURE 14 U.S. POLYMERIZE CHAIN REACTION PCR MARKET, 2016-2023 ($MILLION)
FIGURE 15 U.S. ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT) MARKET, 2016-2023 ($MILLION)
FIGURE 16 U.S. HYBRIDIZATION MARKET, 2016-2023 ($MILLION)
FIGURE 17 U.S. DNA DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 18 U.S. MICROARRAY MARKET, 2016-2023 ($MILLION)
FIGURE 19 U.S. OTHER MOLECULAR DIAGNOSTIC TECHNIQUE MARKET, 2016-2023 ($MILLION)
FIGURE 20 U.S. BASIC METABOLIC PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 21 U.S. LIVER PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 22 U.S. RENAL PROFILE MARKET, 2016-2023 ($MILLION)
FIGURE 23 U.S. LIPID PROFILE MARKET, 2016-2023 ($MILLION)
FIGURE 24 U.S. THYROID FUNCTION PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 25 U.S. ELECTROLYTE PANEL MARKET, 2016-2023 ($MILLION)
FIGURE 26 U.S. SPECIALITY CHEMICALS MARKET, 2016-2023 ($MILLION)
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 28 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 29 THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 30 ALERE INC.: REVENUE, 2014-2016, ($MILLION)
FIGURE 31 ALERE INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 32 ALERE INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 33 BIOMERIEUX REVENUE: 2014-2016 ($MILLION)
FIGURE 34 BIOMERIEUX: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 35 BIOMERIEUX: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 36 DANAHER CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 37 DANAHER CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 38 DANAHER CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 39 ROCHE DIAGNOSTICS: REVENUE, 2014-2016 ($MILLION)
FIGURE 40 ROCHE DIAGNOSTICS: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 41 BECTON, DICKINSON AND COMPANY: REVENUE, 2014-2016 ($MILLION)
FIGURE 42 BECTON DICKINSON AND COMPANY: REVENUES BY SEGMENT (%) (2016)
FIGURE 43 BECTON DICKINSON AND COMPANY: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 44 BIO-RAD LABORATORIES: REVENUE, 2014-2016 ($MILLION)
FIGURE 45 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 46 BIO RAD LABORATORIES, INC.: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 47 BAYER AG: REVENUE, 2014-2016 ($MILLION)
FIGURE 48 BAYER AG: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 49 SYSMEX CORPORATION: REVENUE, 2014-2016 ($MILLION)
FIGURE 50 SYSMEX CORPORATION: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 51 SYSMEX CORPORATION: REVENUE SHARE BY GEOGRAPHY, (2016) (%)
FIGURE 52 JOHNSON & JOHSNON: REVENUE, 2014 - 2016 ($MILLION)
FIGURE 53 JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENTS, (2016) (%)
FIGURE 54 JOHNSON & JOHNSON: REVENUE SHARE BY GEOGRAPHY, (%)(2016)

List of Tables

TABLE 1 INCIDENCE OF DISEASES
TABLE 2 U.S. IVD MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 3 U.S. IVD REAGENTS MARKET, 2016-2023 ($MILLION)
TABLE 4 U.S. IVD INSTRUMENTS MARKET, 2016-2023 ($MILLION)
TABLE 5 U.S. IVD SOFTWARE & SERVICES MARKET, 2016-2023 ($MILLION)
TABLE 6 U.S. IVD MARKET BY TECHNIQUE, 2016-2023 ($MILLION)
TABLE 7 U.S. IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY TYPES, 2016-2023 ($MILLION)
TABLE 8 U.S. IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, 2016-2023 ($MILLION)
TABLE 9 U.S. IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET FOR ELISA, BY TYPES, 2016-2023 ($MILLION)
TABLE 10 U.S. IVD BLOOD TESTING TECHNIQUE MARKET, 2016-2023 ($MILLION)
TABLE 11 U.S. IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 12 U.S. IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, 2016-2023 ($MILLION)
TABLE 13 U.S. IVD TISSUE DIAGNOSTICS TECHNIQUE MARKET, 2016-2023, ($MILLION)
TABLE 14 U.S. IVD CLINICAL CHEMISTRY TECHNIQUE MARKET, 2016-2023 ($MILLION)
TABLE 15 U.S. OTHER IVD TECHNIQUES MARKET, 2016-2023, ($MILLION)
TABLE 16 U.S. IVD MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 17 U.S. IVD INFECTIOUS DISEASES MARKET, 2016-2023 ($MILLION)
TABLE 18 U.S. IVD CANCER MARKET, 2016-2023 ($MILLION)
TABLE 19 U.S. IVD CARDIAC DISEASES MARKET, 2016-2023 ($MILLION)
TABLE 20 U.S. IVD IMMUNE SYSTEM DISORDER MARKET, 2016-2023 ($MILLION)
TABLE 21 U.S. IVD NEPHROLOGICAL DISEASES MARKET, 2016-2023, ($MILLION)
TABLE 22 U.S. IVD GASTROINTESTINAL DISEASES MARKET, 2016-2023 ($MILLION)
TABLE 23 U.S. IVD OTHER INDICATION MARKET, 2016-2023 ($MILLION)
TABLE 24 U.S. IVD MARKET, BY END USER, 2016-2023, ($MILLION)
TABLE 25 U.S. IVD STANDALONE LABORATORIES MARKET, 2016-2023 ($MILLION)
TABLE 26 U.S. IVD HOSPITALS MARKET, 2016-2023 ($MILLION)
TABLE 27 U.S. IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, 2016-2023 ($MILLION)
TABLE 28 U.S. IVD POINT OF CARE MARKET, 2016-2023 ($MILLION)
TABLE 29 U.S. IVD OTHER END-USER MARKET, 2016-2023 ($MILLION)
TABLE 30 THERMO FISHER SCIENTIFIC INC. COMPANY SNAPSHOT
TABLE 31 ALERE INC. COMPANY SNAPSHOT
TABLE 32 BIOMERIEUX COMPANY SNAPSHOT
TABLE 33 DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 34 ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 35 BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 36 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT
TABLE 37 BAYER AG COMPANY SNAPSHOT
TABLE 38 SYSMEX CORPORATION COMPANY SNAPSHOT
TABLE 39 JOHNSON & JOHNSON PVT LTD. COMPANY SNAPSHOT

 

In vitro diagnostics (IVD) are used for early diagnosis of diseases & disorders and treatment management. In addition, they support developing and designing personalized medicine. Advancements in technology and extreme engineering have led to the development of efficient and fully automated medical devices. These technologies have led to the birth of various instruments, such as cardiologic tests, magnetic resonance imaging (MRI), X-ray machines, hearing aids, blood screening instruments, Bio-chips, Radioimmunoassay (RIA), and others.

Immunodiagnostics accounted for the highest share owing to increase in demand for personalized medicine and increase in awareness and ease of use of self-monitoring techniques. In addition, increase in geriatric population and rise in prevalence of chronic and infectious diseases boost the market growth. Blood testing accounted for the highest market potential owing to growth in preference shift of the physicians towards blood-based diagnosis to provide rapid and reliable results. This factor is also anticipated to influence market growth. Furthermore, the increase in government expenditure in healthcare sector is anticipated to increase the market growth. According to the WHO, the U.S. government healthcare expenditure has increased from 20.78% in 2013 to 21.29% in 2014.

Major companies involved in the U.S. IVD market are Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson among others.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
U.S. IVD Market- Opportunity Analysis and Industry Forecast, 2017-2023

  • Single User
  • $2850
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $3423
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $4774
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo